BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
暂无分享,去创建一个
I. Andrulis | G. Glendon | N. Dalay | H. Ozçelik | H. Yazici | N. Cabioğlu | M. Dinçer | P. Saip | E. Bengisu | E. Akisik | O. Bitisik | M. Muslumanoglu | S. Ozbilen | S. Turkmen
[1] G. Giles,et al. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer , 1999, British Journal of Cancer.
[2] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[3] S. Baig,et al. Molecular and population genetic analyses of β‐Thalassemia in Turkey , 1998 .
[4] F. Couch,et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.
[5] B. Ponder,et al. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. , 1997, American journal of human genetics.
[6] M. King,et al. Population genetics of BRCA1 and BRCA2. , 1997, American journal of human genetics.
[7] Steven Gallinger,et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients , 1997, Nature Genetics.
[8] B. Weber,et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. , 1997, American journal of human genetics.
[9] Å. Borg,et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. , 1997, American journal of human genetics.
[10] I. Lerer,et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. , 1997, American journal of human genetics.
[11] D. Easton,et al. High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. , 1996, Cancer research.
[12] D. B. Berman,et al. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. , 1996, Cancer research.
[13] I. Andrulis,et al. Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation , 1996, Human Genetics.
[14] Kenneth Offit,et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer , 1996, Nature Genetics.
[15] J. Rommens,et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.
[16] J. D. Thompson,et al. BRCA1 mutations in a population-based sample of young women with breast cancer. , 1996, The New England journal of medicine.
[17] D. Bentley,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.
[18] M. King,et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. , 1995, American journal of human genetics.
[19] J. Rommens,et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families , 1994, Nature Genetics.
[20] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[21] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[22] D. Easton,et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.
[23] A. Stengrēvics,et al. Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia , 1999, Human mutation.
[24] H. Ozçelik,et al. Molecular and population genetic analyses of beta-thalassemia in Turkey. , 1998, American journal of hematology.
[25] C. Larsson,et al. Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families , 1996, Nature Genetics.
[26] F. Couch,et al. Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene , 1996, Human mutation.